Zota Health Care Limited has announced a significant expansion of its Davaindia pharmacy chain, reaching 1,294 operational stores as of December 4, 2024. The company has notably increased its Company-Owned Company-Operated (COCO) stores from 501 to 601 in just two months.
The shares of Zota Health Care Limited were trading at ₹619.60 up by ₹7.20 or 1.18 per cent on the NSE today at 2.34 pm.
Chairman Ketankumar Zota highlighted the milestone, emphasising the company’s commitment to enhancing direct retail presence and improving healthcare accessibility. The rapid store expansion reflects the company’s growth strategy in the pharmaceutical retail sector.
Founded in 2000 and listed on the National Stock Exchange, Zota Health Care operates with a team of over 470 professionals. The company specialises in developing, manufacturing, and marketing pharmaceutical, ayurvedic, nutraceutical, and over-the-counter products. Its Davaindia pharmacy chain, launched in 2017, offers over 2,000 stock-keeping units (SKUs) of quality medicines.
The company’s strategic approach includes backward and forward integration, with a focus on efficient product lifecycle management. Zota continues to invest in research and development, positioning itself as an innovative player in the Indian healthcare industry.
